ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Movymia 250 μg/mL, Injektionslösung - 
66818001 Spirig HealthCare AG
Movymia 250 μg/mL, Injektionslösung17.10.2018
  17.10.2018
Teriparatide (H05AA02) 
WHO-DDD 
07.99. 
07.99. 
B  
Yes 
IPCI
239.81Yes
    
10 %278.40
7680668180011Biotechnologika
7745235 
Composition
teriparatidum ADNr 250 µg, acidum aceticum glaciale, natrii acetas trihydricus, mannitolum, metacresolum, acidum hydrochloridum ad pH, natrii hydroxidum ad pH, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 0.03 mg.
Packungsbestandteile
Injection solution 
  
 
Active AgentDose
Teriparatidum Adnr250 µg/ml
BAG: Active AgentDose
Teriparatidum Adnr250 mcg
 
Inactive agents
Acidum Aceticum Glaciale
Acidum Hydrochloridum ad Ph
Mannitol
Metacresol
Sodium Acetate Trihydrate
Natrii Hydroxidum ad Ph
 
Source
Data was imported : 07.08.2025 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home